Syndax Pharmaceuticals, Inc. announced a private placement of 1,421,523 shares at a price of $24.62 per share for gross proceeds of $35 million on September 24, 2021. The transaction will include participation from Incyte Corporation.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.28 USD | +1.02% | +1.77% | -1.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.30% | 1.79B | |
+2.01% | 42.75B | |
+47.58% | 41.61B | |
+12.03% | 41.34B | |
-12.36% | 26.59B | |
+7.72% | 25.49B | |
-23.11% | 18.12B | |
+30.55% | 12.24B | |
-2.13% | 11.76B | |
+8.11% | 11B |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- Syndax Pharmaceuticals, Inc. announced that it expects to receive $34.997896 million in funding from Incyte Corporation